|

utidelone Clinical Trials

4 actively recruiting trials across 1 location

Also known as: UTD1

Pipeline

Phase 2: 3Phase 3: 1

Top Sponsors

  • Sun Yat-sen University1
  • Huihua Xiong1
  • Guangdong Provincial People's Hospital1
  • Biostar Pharma, Inc.1

Indications

  • Breast Cancer4
  • Cancer4
  • HER2-negative Breast Cancer Patients With Brain Metastases1
  • TNBC - Triple-Negative Breast Cancer1
  • HER2-negative Breast Cancer1

Other3 trials

Organoid-based Functional Precision Therapy for Advanced Breast Cancer
Phase 2
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
Phase 2
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
Phase 3

Duarte, California1 trial

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

City of Hope--Duarte

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.